July 2, 2015: Biogen and AGTC today announced a broad collaboration and license agreement to develop gene-based therapies for multiple ophthalmic diseases. The collaboration will focus on the development of a portfolio of AGTC’s therapeutic programs.
2015: Celgene is officially the mystery buyer of Merck’s former 1 million-square-foot headquarters in Whitehouse Station, N.J., the company announced Wednesday, ending months of speculation.
July 2, 2015: The U.S. CMS yesterday published data indicating that New York University of Rochester professor emeritus John Bennett received $138,986 in compensation from Celgene..
July 2, 2015: Novo Nordisk is to stop selling its new long-acting insulin drug Tresiba in Germany following a row over pricing. The decision is the latest example of tensions between drugmakers and healthcare providers, many of whom are unhappy.